Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer Patients

Fresh Platinum Complexes with Promising Antitumor Activity

(2012) Xiaoyong Wang   Anti-Cancer Agents in Medicinal Chemistry

Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC)

(2012) K. L. Bolton et al.   JOURNAL OF INTERNAL MEDICINE

Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility

(2012) D. Ziliak et al.   MOLECULAR CANCER THERAPEUTICS

Genome Wide DNA Copy Number Analysis of Serous Type Ovarian Carcinomas Identifies Genetic Markers Predictive of Clinical Outcome

(2012) David A. Engler et al.   PLoS One

Accounting for multiple comparisons in a genome-wide association study (GWAS)

(2011) Randall C Johnson et al.   BMC GENOMICS

Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer

(2011) Chan H Han et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Quantitative prediction of tumor response to neoadjuvant chemotherapy in breast cancer: novel marker genes and prediction model using the expression levels

(2011) Hiroshi Sano et al.   Breast Cancer

Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma

(2010) Koji Matsuo et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application

(2010) Rita M. Cantor et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin

(2010) Megan D. Indermaur et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study

(2010) Peter G. Rose et al.   GYNECOLOGIC ONCOLOGY

Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells

(2010) Hyun Chang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Common variants at 19p13 are associated with susceptibility to ovarian cancer

(2010) Kelly L Bolton et al.   NATURE GENETICS

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

(2010) K. Wang et al.   NUCLEIC ACIDS RESEARCH

The Sequence Alignment/Map format and SAMtools

(2009) H. Li et al.   BIOINFORMATICS

Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis

(2009) R Fernández-Ramires et al.   BRITISH JOURNAL OF CANCER

Role of genetic polymorphisms and ovarian cancer susceptibility

(2009) Peter A. Fasching et al.   Molecular Oncology

Rapid and Accurate Multiple Testing Correction and Power Estimation for Millions of Correlated Markers

(2009) Buhm Han et al.   PLoS Genetics

Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival

(2008) F. Bartel et al.   CLINICAL CANCER RESEARCH